CoverageForm 410-K10-Q8-K13D13G13F

MRMD Marimed Inc. - 8-K

Filed Mar 11, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0001522767-26-000027
2.029.01

Item 2.02 - Results of Operations and Financial Condition

Earnings press release item. The actual results are typically in Exhibit 99.1 - fetch may not have completed.

Item 2.02. Results of Operations and Financial Condition.

On March 11, 2026, MariMed Inc. (the “Company”) issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference, announcing its financial results for the three months and year ended December 31, 2025.

Item 9.01 - Financial Statements and Exhibits

143 words

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit

No.

Description

99.1

Press release, dated March 11, 2026, announcing financial results for the three months and year ended December 31, 2025.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, furnished pursuant to Item 2.02, including Exhibit 99.1 shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

**********